Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years
Status:
Not yet recruiting
Trial end date:
2027-12-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the outcomes, tolerability and safety of 2 different
doses of oral pantoprazole (full healing dose, half healing dose), assigned based upon
weight, for the maintenance of healing of erosive esophagitis in pediatric participants aged
1 to 17 years with endoscopically-confirmed, healed erosive esophagitis.